Millian, Craig

Track

Insider profile

Performance

Overall performance
0.8
Performance over holding periods
0.8
30 days 90 days 120 days
Average return -11% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Millian, Craig's trades of HLS Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
388.77
Quantity 82,866 -32.4%
Value US$3,197,044
Transaction date
Purchase
Price
120.58
Quantity 18,720 +17.2%
Value US$3,703,624
Transaction date
Purchase
Price
451.50
Quantity 84,169 -37.3%
Value US$1,310,100
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-18 2026-08-17
B Purchase
82,866 -32.4%
388.77
US$3,197,044 		82,866 -32.4% 388.77 US$3,197,044
2026-06-17 2026-06-17
B Purchase
18,720 +17.2%
120.58
US$3,703,624 		18,720 +17.2% 120.58 US$3,703,624
2024-05-16 2024-05-15
B Purchase
84,169 -37.3%
451.50
US$1,310,100 		84,169 -37.3% 451.50 US$1,310,100